This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Recent advancements in brain-computer interfaces are helping restore communication in clinical trial participants who have lost the ability to speak or make voluntary movements. New findings were presented at Neuroscience 2026, the annual meeting of the Society for Neuroscience.
Brain-computer interfaces (BCIs) record a person's brain signals and translate them into commands to control computers, prosthetic limbs or other devices. The technology is still largely experimental but shows promise for restoring functions lost due to amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), stroke and other neurological disorders.
Reflecting this potential, the global BCI market is projected to increase from $1.7 billion in 2022 to $6.2 billion by 2030. Clinical trials of BCIs that help people with paralysis communicate are moving these devices closer to real-world applications and deepening researchers' understanding of how the brain produces speech.
"The ability to decode and convert brain activity into spoken or written words has life-changing potential for people with paralysis," says event moderator Cynthia Chestek, a biomedical engineer at the University of Michigan who works on implantable BCIs for neural control of prosthetic limbs and other assistive technology.
"The work presented today brings brain-to-voice and brain-to-text technologies closer to reaching people outside of clinical trials, which is extremely exciting."
Source link







